Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors

被引：17
|
作者：
Yamamoto, Takaya [1 ]
Niibe, Yuzuru [2 ,3 ]
Matsumoto, Yasuo [4 ]
Dekura, Yasuhiro [5 ]
Oh, Ryoong-Jin [6 ]
Yamashita, Hideomi [7 ]
Kakuhara, Hisao [8 ]
Aoki, Masahiko [9 ]
Jingu, Keiichi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi, Japan
[2] Toho Univ, Omori Med Ctr, Dept Radiol, Tokyo, Japan
[3] Okayama Univ, Dept Primary Care & Med Educ, Okayama, Japan
[4] Niigata Canc Ctr, Dept Radiat Oncol, Niigata, Japan
[5] Keiyu Kai Sapporo Hosp, Dept Radiat Oncol, Sapporo, Hokkaido, Japan
[6] Miyakojima IGRT Clin, Dept Radiat Oncol, Osaka, Japan
[7] Univ Tokyo, Dept Radiol, Tokyo, Japan
[8] Iwate Med Univ Hosp, Dept Radiol, Morioka, Iwate, Japan
[9] Hirosaki Univ, Dept Radiat Oncol, Hirosaki, Aomori, Japan
来源：
ANTICANCER RESEARCH | 2020年 / 40卷 / 04期
关键词：
Stereotactic body radiotherapy (SBRT); oligometastases; oligo-recurrence; esophageal cancer; prognostic factor; OLIGO-RECURRENCE; RADIATION-THERAPY; MULTIMODALITY THERAPY; LUNG METASTASES; OUTCOMES;
D O I：
10.21873/anticanres.14164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: The aim of this multi-center retrospective study was to investigate the results of stereotactic body radiotherapy (SBRT) for pulmonary oligometastases from esophageal cancer. Patients and Methods: Oligometastases from the esophagus were identified from a dataset of a Japanese survey. The Kaplan-Meier method and Cox regression were applied to perform analyses. Results: A total of 114 patients with 132 pulmonary oligometastases were collected. The 3-year local control rate, freedom from further metastasis (FFFM) rate and overall survival (OS) rate were 70.2%, 25.3% and 37.5%, respectively. Performance status (PS) (PS 1 vs. PS 0, p<0.01), disease-free interval (p=0.03) and history of local therapy for metastasis (p=0.01) had significant relationships with FFFM and only PS was an independent prognostic factor for OS (PS 1 vs. PS 0, p=0.02; PS 2-3 vs. PS 0, p=0.04). Conclusion: SBRT for pulmonary oligometastases from esophageal cancer provided good local control and survival.
引用
收藏
页码：2065 / 2072
页数：8
相关论文
共 50 条
  • [1] Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy
    Sharma, Aman
    Duijm, Marloes
    Oomen-de Hoop, Esther
    Aerts, Joachim G.
    Verhoef, Cornelis
    Hoogeman, Mischa
    Nuyttens, Joost Jan
    [J]. ACTA ONCOLOGICA, 2019, 58 (01) : 74 - 80
  • [2] STEREOTACTIC BODY RADIOTHERAPY FOR PULMONARY OLIGOMETASTASES
    Lagerwaard, F. J.
    [J]. LUNG CANCER, 2011, 71 : S17 - S17
  • [3] Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors
    Cuccia, Francesco
    Mazzola, Rosario
    Figlia, Vanessa
    Giaj-Levra, Niccolo
    Nicosia, Luca
    Ricchetti, Francesco
    Rigo, Michele
    Attina, Giorgio
    Vitale, Claudio
    Pastorello, Edoardo
    Ruggieri, Ruggero
    Alongi, Filippo
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 934 - 939
  • [4] Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors
    Francesco Cuccia
    Rosario Mazzola
    Vanessa Figlia
    Niccolò Giaj-Levra
    Luca Nicosia
    Francesco Ricchetti
    Michele Rigo
    Giorgio Attinà
    Claudio Vitale
    Edoardo Pastorello
    Ruggero Ruggieri
    Filippo Alongi
    [J]. Strahlentherapie und Onkologie, 2022, 198 : 934 - 939
  • [5] Management of pulmonary oligometastases by stereotactic body radiotherapy
    Gamsiz, Hakan
    Beyzadeoglu, Murat
    Sager, Omer
    Dincoglan, Ferrat
    Demiral, Selcuk
    Uysal, Bora
    Surenkok, Serdar
    Oysul, Kaan
    Dirican, Bahar
    [J]. TUMORI, 2014, 100 (02) : 179 - 183
  • [6] Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy
    Sharma, Aman
    Baker, Sarah
    Duijm, Marloes
    Oomen-de Hoop, Esther
    Cornelissen, Robin
    Verhoef, Cornelis
    Hoogeman, Mischa
    Nuyttens, Joost Jan
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 144 : 23 - 29
  • [7] Stereotactic robotic body radiotherapy for patients with pulmonary oligometastases
    Berkovic, P.
    Gulyban, A.
    Swenen, L.
    Dechambre, D.
    Nguyen, P. Viet
    Jansen, N.
    Mievis, C.
    Bartelemy, N.
    Lovinfosse, P.
    Bare, M.
    Lakosi, F.
    Janvary, L.
    Coucke, P. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S661 - S662
  • [8] Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
    Sharma, Aman
    Duijm, Marloes
    Oomen-de Hoop, Esther
    Aerts, Joachim G.
    Verhoef, Cornelis
    Hoogeman, Mischa
    Nuyttens, Joost Jan
    [J]. ACTA ONCOLOGICA, 2018, 57 (08) : 1031 - 1037
  • [9] Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
    Li, Shuai
    Dong, Dezuo
    Geng, Jianhao
    Zhu, Xianggao
    Shi, Chen
    Zhang, Yangzi
    Wang, Hongzhi
    Zhou, Shun
    Wu, Hao
    Cai, Yong
    Li, Yongheng
    Wang, Weihu
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study
    Piao, Mei-Na
    Xie, Jing
    Mn, Min-Min
    Ma, Xiao-Tin
    Dou, Zheng
    Wang, Jian-Pin
    Li, JIn-Li
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (08) : 1950 - 1963
12345